Daniel Steiner
Senior Vice President - Oncology Research Molecular Partners AG
Seminars
Wednesday 12th November 2025
Internalisation of Targeted Radiopharmaceuticals: Strategic Imperative or Situational Choice?
1:30 pm
- DARPin optimizations to achieve an RLT suitable profile via iterative design – test cycles
- Integrating of these insights for optimized lead selection of the next programs
- How this differs from standard RLT vector development and allows to optimize timelines, costs, resources
